 | • レポートコード：GIR-107A12643 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、迅速抗原検査のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。迅速抗原検査の種類別市場規模（免疫吸着測定法、酵素免疫測定法、沈殿反応、ラジオイムノアッセイ、凝集反応、補体固定）、用途別市場規模（病院、専門クリニック、診断センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・迅速抗原検査の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott Laboratories、F. Hoffmann-La Roche、Oxford BioMedica、Affinity Biologicals、Epitope Diagnostics、Sino Biological、R-Biopharma、Cell Biolabs、Thermo Fisher Scientific、Bio-Rad Laboratories ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：免疫吸着測定法、酵素免疫測定法、沈殿反応、ラジオイムノアッセイ、凝集反応、補体固定 ・用途別分析2016年-2026年：病院、専門クリニック、診断センター、その他 ・迅速抗原検査の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・迅速抗原検査のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・迅速抗原検査のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・迅速抗原検査の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・迅速抗原検査の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Rapid Antigen Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Rapid Antigen Testing size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Rapid Antigen Testing market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Rapid Antigen Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Immunosorbent Assay
Enzyme-linked Immunosorbent
Precipitation Reaction
Radioimmunoassay
Agglutination Reaction
Complement Fixatio
Market segment by Application, can be divided into
Hospitals
Specialty Clinics
Diagnostic Centers
Others
Market segment by players, this report covers
Abbott Laboratories
F. Hoffmann-La Roche
Oxford BioMedica
Affinity Biologicals
Epitope Diagnostics
Sino Biological
R-Biopharma
Cell Biolabs
Thermo Fisher Scientific
Bio-Rad Laboratories
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Rapid Antigen Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Rapid Antigen Testing, with revenue, gross margin and global market share of Rapid Antigen Testing from 2019 to 2021.
Chapter 3, the Rapid Antigen Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Rapid Antigen Testing market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Rapid Antigen Testing research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Rapid Antigen Testing
1.2 Classification of Rapid Antigen Testing by Type
1.2.1 Overview: Global Rapid Antigen Testing Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Rapid Antigen Testing Revenue Market Share by Type in 2020
1.2.3 Immunosorbent Assay
1.2.4 Enzyme-linked Immunosorbent
1.2.5 Precipitation Reaction
1.2.6 Radioimmunoassay
1.2.7 Agglutination Reaction
1.2.8 Complement Fixatio
1.3 Global Rapid Antigen Testing Market by Application
1.3.1 Overview: Global Rapid Antigen Testing Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Diagnostic Centers
1.3.5 Others
1.4 Global Rapid Antigen Testing Market Size & Forecast
1.5 Global Rapid Antigen Testing Market Size and Forecast by Region
1.5.1 Global Rapid Antigen Testing Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Rapid Antigen Testing Market Size by Region, (2016-2021)
1.5.3 North America Rapid Antigen Testing Market Size and Prospect (2016-2026)
1.5.4 Europe Rapid Antigen Testing Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Rapid Antigen Testing Market Size and Prospect (2016-2026)
1.5.6 South America Rapid Antigen Testing Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Rapid Antigen Testing Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Rapid Antigen Testing Market Drivers
1.6.2 Rapid Antigen Testing Market Restraints
1.6.3 Rapid Antigen Testing Trends Analysis
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Rapid Antigen Testing Product and Solutions
2.1.4 Abbott Laboratories Rapid Antigen Testing Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 F. Hoffmann-La Roche
2.2.1 F. Hoffmann-La Roche Details
2.2.2 F. Hoffmann-La Roche Major Business
2.2.3 F. Hoffmann-La Roche Rapid Antigen Testing Product and Solutions
2.2.4 F. Hoffmann-La Roche Rapid Antigen Testing Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.3 Oxford BioMedica
2.3.1 Oxford BioMedica Details
2.3.2 Oxford BioMedica Major Business
2.3.3 Oxford BioMedica Rapid Antigen Testing Product and Solutions
2.3.4 Oxford BioMedica Rapid Antigen Testing Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Oxford BioMedica Recent Developments and Future Plans
2.4 Affinity Biologicals
2.4.1 Affinity Biologicals Details
2.4.2 Affinity Biologicals Major Business
2.4.3 Affinity Biologicals Rapid Antigen Testing Product and Solutions
2.4.4 Affinity Biologicals Rapid Antigen Testing Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Affinity Biologicals Recent Developments and Future Plans
2.5 Epitope Diagnostics
2.5.1 Epitope Diagnostics Details
2.5.2 Epitope Diagnostics Major Business
2.5.3 Epitope Diagnostics Rapid Antigen Testing Product and Solutions
2.5.4 Epitope Diagnostics Rapid Antigen Testing Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Epitope Diagnostics Recent Developments and Future Plans
2.6 Sino Biological
2.6.1 Sino Biological Details
2.6.2 Sino Biological Major Business
2.6.3 Sino Biological Rapid Antigen Testing Product and Solutions
2.6.4 Sino Biological Rapid Antigen Testing Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Sino Biological Recent Developments and Future Plans
2.7 R-Biopharma
2.7.1 R-Biopharma Details
2.7.2 R-Biopharma Major Business
2.7.3 R-Biopharma Rapid Antigen Testing Product and Solutions
2.7.4 R-Biopharma Rapid Antigen Testing Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 R-Biopharma Recent Developments and Future Plans
2.8 Cell Biolabs
2.8.1 Cell Biolabs Details
2.8.2 Cell Biolabs Major Business
2.8.3 Cell Biolabs Rapid Antigen Testing Product and Solutions
2.8.4 Cell Biolabs Rapid Antigen Testing Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Cell Biolabs Recent Developments and Future Plans
2.9 Thermo Fisher Scientific
2.9.1 Thermo Fisher Scientific Details
2.9.2 Thermo Fisher Scientific Major Business
2.9.3 Thermo Fisher Scientific Rapid Antigen Testing Product and Solutions
2.9.4 Thermo Fisher Scientific Rapid Antigen Testing Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.10 Bio-Rad Laboratories
2.10.1 Bio-Rad Laboratories Details
2.10.2 Bio-Rad Laboratories Major Business
2.10.3 Bio-Rad Laboratories Rapid Antigen Testing Product and Solutions
2.10.4 Bio-Rad Laboratories Rapid Antigen Testing Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Bio-Rad Laboratories Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Rapid Antigen Testing Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Rapid Antigen Testing Players Market Share
3.2.2 Top 10 Rapid Antigen Testing Players Market Share
3.2.3 Market Competition Trend
3.3 Rapid Antigen Testing Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Rapid Antigen Testing Revenue and Market Share by Type (2016-2021)
4.2 Global Rapid Antigen Testing Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Rapid Antigen Testing Revenue Market Share by Application (2016-2021)
5.2 Rapid Antigen Testing Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Rapid Antigen Testing Revenue by Type (2016-2026)
6.2 North America Rapid Antigen Testing Revenue by Application (2016-2026)
6.3 North America Rapid Antigen Testing Market Size by Country
6.3.1 North America Rapid Antigen Testing Revenue by Country (2016-2026)
6.3.2 United States Rapid Antigen Testing Market Size and Forecast (2016-2026)
6.3.3 Canada Rapid Antigen Testing Market Size and Forecast (2016-2026)
6.3.4 Mexico Rapid Antigen Testing Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Rapid Antigen Testing Revenue by Type (2016-2026)
7.2 Europe Rapid Antigen Testing Revenue by Application (2016-2026)
7.3 Europe Rapid Antigen Testing Market Size by Country
7.3.1 Europe Rapid Antigen Testing Revenue by Country (2016-2026)
7.3.2 Germany Rapid Antigen Testing Market Size and Forecast (2016-2026)
7.3.3 France Rapid Antigen Testing Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Rapid Antigen Testing Market Size and Forecast (2016-2026)
7.3.5 Russia Rapid Antigen Testing Market Size and Forecast (2016-2026)
7.3.6 Italy Rapid Antigen Testing Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Rapid Antigen Testing Revenue by Type (2016-2026)
8.2 Asia-Pacific Rapid Antigen Testing Revenue by Application (2016-2026)
8.3 Asia-Pacific Rapid Antigen Testing Market Size by Region
8.3.1 Asia-Pacific Rapid Antigen Testing Revenue by Region (2016-2026)
8.3.2 China Rapid Antigen Testing Market Size and Forecast (2016-2026)
8.3.3 Japan Rapid Antigen Testing Market Size and Forecast (2016-2026)
8.3.4 South Korea Rapid Antigen Testing Market Size and Forecast (2016-2026)
8.3.5 India Rapid Antigen Testing Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Rapid Antigen Testing Market Size and Forecast (2016-2026)
8.3.7 Australia Rapid Antigen Testing Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Rapid Antigen Testing Revenue by Type (2016-2026)
9.2 South America Rapid Antigen Testing Revenue by Application (2016-2026)
9.3 South America Rapid Antigen Testing Market Size by Country
9.3.1 South America Rapid Antigen Testing Revenue by Country (2016-2026)
9.3.2 Brazil Rapid Antigen Testing Market Size and Forecast (2016-2026)
9.3.3 Argentina Rapid Antigen Testing Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Rapid Antigen Testing Revenue by Type (2016-2026)
10.2 Middle East & Africa Rapid Antigen Testing Revenue by Application (2016-2026)
10.3 Middle East & Africa Rapid Antigen Testing Market Size by Country
10.3.1 Middle East & Africa Rapid Antigen Testing Revenue by Country (2016-2026)
10.3.2 Turkey Rapid Antigen Testing Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Rapid Antigen Testing Market Size and Forecast (2016-2026)
10.3.4 UAE Rapid Antigen Testing Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Rapid Antigen Testing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Rapid Antigen Testing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Rapid Antigen Testing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Rapid Antigen Testing Revenue (USD Million) by Region (2016-2021)
Table 5. Global Rapid Antigen Testing Revenue Market Share by Region (2021-2026)
Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Laboratories Major Business
Table 8. Abbott Laboratories Rapid Antigen Testing Product and Solutions
Table 9. Abbott Laboratories Rapid Antigen Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors
Table 11. F. Hoffmann-La Roche Major Business
Table 12. F. Hoffmann-La Roche Rapid Antigen Testing Product and Solutions
Table 13. F. Hoffmann-La Roche Rapid Antigen Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Oxford BioMedica Corporate Information, Head Office, and Major Competitors
Table 15. Oxford BioMedica Major Business
Table 16. Oxford BioMedica Rapid Antigen Testing Product and Solutions
Table 17. Oxford BioMedica Rapid Antigen Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Affinity Biologicals Corporate Information, Head Office, and Major Competitors
Table 19. Affinity Biologicals Major Business
Table 20. Affinity Biologicals Rapid Antigen Testing Product and Solutions
Table 21. Affinity Biologicals Rapid Antigen Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Epitope Diagnostics Corporate Information, Head Office, and Major Competitors
Table 23. Epitope Diagnostics Major Business
Table 24. Epitope Diagnostics Rapid Antigen Testing Product and Solutions
Table 25. Epitope Diagnostics Rapid Antigen Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Sino Biological Corporate Information, Head Office, and Major Competitors
Table 27. Sino Biological Major Business
Table 28. Sino Biological Rapid Antigen Testing Product and Solutions
Table 29. Sino Biological Rapid Antigen Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. R-Biopharma Corporate Information, Head Office, and Major Competitors
Table 31. R-Biopharma Major Business
Table 32. R-Biopharma Rapid Antigen Testing Product and Solutions
Table 33. R-Biopharma Rapid Antigen Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Cell Biolabs Corporate Information, Head Office, and Major Competitors
Table 35. Cell Biolabs Major Business
Table 36. Cell Biolabs Rapid Antigen Testing Product and Solutions
Table 37. Cell Biolabs Rapid Antigen Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 39. Thermo Fisher Scientific Major Business
Table 40. Thermo Fisher Scientific Rapid Antigen Testing Product and Solutions
Table 41. Thermo Fisher Scientific Rapid Antigen Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 43. Bio-Rad Laboratories Major Business
Table 44. Bio-Rad Laboratories Rapid Antigen Testing Product and Solutions
Table 45. Bio-Rad Laboratories Rapid Antigen Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Rapid Antigen Testing Revenue (USD Million) by Players (2019-2021)
Table 47. Global Rapid Antigen Testing Revenue Share by Players (2019-2021)
Table 48. Breakdown of Rapid Antigen Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Rapid Antigen Testing Players Head Office, Products and Services Provided
Table 50. Rapid Antigen Testing Mergers & Acquisitions in the Past Five Years
Table 51. Rapid Antigen Testing New Entrants and Expansion Plans
Table 52. Global Rapid Antigen Testing Revenue (USD Million) by Type (2016-2021)
Table 53. Global Rapid Antigen Testing Revenue Share by Type (2016-2021)
Table 54. Global Rapid Antigen Testing Revenue Forecast by Type (2021-2026)
Table 55. Global Rapid Antigen Testing Revenue by Application (2016-2021)
Table 56. Global Rapid Antigen Testing Revenue Forecast by Application (2021-2026)
Table 57. North America Rapid Antigen Testing Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Rapid Antigen Testing Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Rapid Antigen Testing Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Rapid Antigen Testing Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Rapid Antigen Testing Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Rapid Antigen Testing Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Rapid Antigen Testing Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Rapid Antigen Testing Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Rapid Antigen Testing Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Rapid Antigen Testing Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Rapid Antigen Testing Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Rapid Antigen Testing Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Rapid Antigen Testing Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Rapid Antigen Testing Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Rapid Antigen Testing Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Rapid Antigen Testing Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Rapid Antigen Testing Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Rapid Antigen Testing Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Rapid Antigen Testing Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Rapid Antigen Testing Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Rapid Antigen Testing Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Rapid Antigen Testing Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Rapid Antigen Testing Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Rapid Antigen Testing Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Rapid Antigen Testing Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Rapid Antigen Testing Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Rapid Antigen Testing Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Rapid Antigen Testing Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Rapid Antigen Testing Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Rapid Antigen Testing Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Rapid Antigen Testing Picture
Figure 2. Global Rapid Antigen Testing Revenue Market Share by Type in 2020
Figure 3. Immunosorbent Assay
Figure 4. Enzyme-linked Immunosorbent
Figure 5. Precipitation Reaction
Figure 6. Radioimmunoassay
Figure 7. Agglutination Reaction
Figure 8. Complement Fixatio
Figure 9. Rapid Antigen Testing Revenue Market Share by Application in 2020
Figure 10. Hospitals Picture
Figure 11. Specialty Clinics Picture
Figure 12. Diagnostic Centers Picture
Figure 13. Others Picture
Figure 14. Global Rapid Antigen Testing Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 15. Global Rapid Antigen Testing Revenue and Forecast (2016-2026) & (USD Million)
Figure 16. Global Rapid Antigen Testing Revenue Market Share by Region (2016-2026)
Figure 17. Global Rapid Antigen Testing Revenue Market Share by Region in 2020
Figure 18. North America Rapid Antigen Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Europe Rapid Antigen Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Asia-Pacific Rapid Antigen Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. South America Rapid Antigen Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Middle East and Africa Rapid Antigen Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. Rapid Antigen Testing Market Drivers
Figure 24. Rapid Antigen Testing Market Restraints
Figure 25. Rapid Antigen Testing Market Trends
Figure 26. Abbott Laboratories Recent Developments and Future Plans
Figure 27. F. Hoffmann-La Roche Recent Developments and Future Plans
Figure 28. Oxford BioMedica Recent Developments and Future Plans
Figure 29. Affinity Biologicals Recent Developments and Future Plans
Figure 30. Epitope Diagnostics Recent Developments and Future Plans
Figure 31. Sino Biological Recent Developments and Future Plans
Figure 32. R-Biopharma Recent Developments and Future Plans
Figure 33. Cell Biolabs Recent Developments and Future Plans
Figure 34. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 35. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 36. Global Rapid Antigen Testing Revenue Share by Players in 2020
Figure 37. Rapid Antigen Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 38. Global Top 3 Players Rapid Antigen Testing Revenue Market Share in 2020
Figure 39. Global Top 10 Players Rapid Antigen Testing Revenue Market Share in 2020
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 41. Global Rapid Antigen Testing Revenue Share by Type in 2020
Figure 42. Global Rapid Antigen Testing Market Share Forecast by Type (2021-2026)
Figure 43. Global Rapid Antigen Testing Revenue Share by Application in 2020
Figure 44. Global Rapid Antigen Testing Market Share Forecast by Application (2021-2026)
Figure 45. North America Rapid Antigen Testing Sales Market Share by Type (2016-2026)
Figure 46. North America Rapid Antigen Testing Sales Market Share by Application (2016-2026)
Figure 47. North America Rapid Antigen Testing Revenue Market Share by Country (2016-2026)
Figure 48. United States Rapid Antigen Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Canada Rapid Antigen Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Mexico Rapid Antigen Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Europe Rapid Antigen Testing Sales Market Share by Type (2016-2026)
Figure 52. Europe Rapid Antigen Testing Sales Market Share by Application (2016-2026)
Figure 53. Europe Rapid Antigen Testing Revenue Market Share by Country (2016-2026)
Figure 54. Germany Rapid Antigen Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France Rapid Antigen Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom Rapid Antigen Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia Rapid Antigen Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy Rapid Antigen Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific Rapid Antigen Testing Sales Market Share by Type (2016-2026)
Figure 60. Asia-Pacific Rapid Antigen Testing Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Rapid Antigen Testing Revenue Market Share by Region (2016-2026)
Figure 62. China Rapid Antigen Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Rapid Antigen Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South Korea Rapid Antigen Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Rapid Antigen Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Rapid Antigen Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Rapid Antigen Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Rapid Antigen Testing Sales Market Share by Type (2016-2026)
Figure 69. South America Rapid Antigen Testing Sales Market Share by Application (2016-2026)
Figure 70. South America Rapid Antigen Testing Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Rapid Antigen Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Rapid Antigen Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East and Africa Rapid Antigen Testing Sales Market Share by Type (2016-2026)
Figure 74. Middle East and Africa Rapid Antigen Testing Sales Market Share by Application (2016-2026)
Figure 75. Middle East and Africa Rapid Antigen Testing Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Rapid Antigen Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Rapid Antigen Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. UAE Rapid Antigen Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source
世界の前立腺特異抗原（PSA）検査市場 2021：企業別、地域別、種類・用途別 The Prostate-specific Antigen (PSA) Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…- 世界のLFAベース迅速検査ソリューション市場 2021：企業別、地域別、種類・用途別 The LFA-based Rapid Testing Solutions market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
- 前立腺特異抗原（PSA）テストの世界市場 2019年版：種類別（CLIA法、ELISA法）、用途別（スクリーニング、治療後モニタリング、その他） Scope of the Report: The global Prostate-specific Antigen (PSA) Testing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especi…
- 世界の迅速検査装置市場 2021：企業別、地域別、種類・用途別 The Rapid Testing Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 世界の急速凝固試験市場予測（～2024年） Rapid coagulation testing can be defined as the rapid specific testing of bodily blood fluids at the bedside. The rapid coagulation testing are being widely used for management of perioperative coagulation. Scope of the Report: The global Rapid Coagulation Testing market is valued at xx million USD …